Evidence map›Paper›PMID 36277378›Full record

ArticleFrontiers in bioengineering and biotechnology2022

The inhibiting effect of alpha-based TARE on embolized vessels and neovascularization.

Qianqian Tong, Rou Li, Ruizhi Wang, Changjing Zuo, Danni Li, Guorong Jia, Ye Peng, Xiaohong Li, Jian Yang, Shuai Xue and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Qianqian TongSchool of Chemistry and Bioengineering, Yichun University, Yichun, Jiangxi, China.
Rou LiDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.
Ruizhi WangDepartment of Radiology, Huadong Hospital, Fudan University, Shanghai, China.
Changjing ZuoDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.
Danni LiDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.
Guorong JiaDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.
Ye PengDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.
Xiaohong LiDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.
Jian YangDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.
Shuai XueSchool of Chemistry and Bioengineering, Yichun University, Yichun, Jiangxi, China.
Qingyun BaiSchool of Chemistry and Bioengineering, Yichun University, Yichun, Jiangxi, China.
Xiao LiDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai, China.
Second Military Medical University · CNFudan University · CNYichun University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transarterial embolization (TAE) is a personalized technology that offers precise delivery of chemotherapeutic drugs or selective internal radiation therapy for hepatocellular carcinoma (HCC). Beta-emitting radionuclide embolisms for TAE (β-based TARE) are commonly used in the clinic

Indexed as

hepatocellular carcinomanecrosisneovascularizationRa-223silk fibrointransarterial radioembolizationα radionuclides

Identifiers

PMID36277378
PMCPMC9585162
OpenAlexW4303021215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.